Published in J Am Vet Med Assoc on June 01, 1993
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med (1998) 5.14
Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res (1991) 1.61
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Exp Hematol (1996) 1.47
Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989). J Am Vet Med Assoc (1995) 1.30
Phase II evaluation of doxorubicin for treatment of various canine neoplasms. J Am Vet Med Assoc (1989) 1.23
Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc (1997) 1.21
Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. J Vet Intern Med (2004) 1.21
Multilobular osteochondrosarcoma in 39 dogs: 1979-1993. J Am Anim Hosp Assoc (1998) 1.20
Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med (2000) 1.18
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours. Vet Comp Oncol (2011) 1.15
Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J Vet Intern Med (1996) 1.15
Epidemiologic studies of risk factors for cancer in pet dogs. Epidemiol Rev (1998) 1.12
Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound (2001) 1.12
Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats. J Vet Intern Med (1998) 1.09
Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med (1999) 1.09
Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991). J Am Vet Med Assoc (1993) 1.09
In vitro suppression of normal granulocytic stem cells by inhibitory activity derived from human leukemia cells. J Natl Cancer Inst (1978) 1.08
Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med (1991) 1.05
Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000). J Am Vet Med Assoc (2001) 1.05
Development of inhalational agents for oncologic use. J Clin Oncol (2001) 1.05
Thymoma in dogs: 23 cases (1980-1991). J Am Vet Med Assoc (1994) 1.05
Acute and chronic adaptations of muscle proprioceptors in response to increased use. Sports Med (1992) 1.03
Infiltrative lipoma in dogs: 16 cases (1981-1992). J Am Vet Med Assoc (1994) 1.02
Prophylactic trimethoprim-sulfadiazine during chemotherapy in dogs with lymphoma and osteosarcoma: a double-blind, placebo-controlled study. J Vet Intern Med (2007) 1.02
Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model. Clin Cancer Res (1998) 1.01
Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). J Am Anim Hosp Assoc (1998) 1.00
Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Clin Cancer Res (1995) 0.99
A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. J Vet Intern Med (1999) 0.99
Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc (1991) 0.97
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res (1999) 0.97
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol (2006) 0.97
Multilobular osteochondrosarcoma of the hard palate in a dog. Aust Vet J (2004) 0.96
Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma. Cancer (1993) 0.95
Primary rib tumors in 54 dogs. J Am Anim Hosp Assoc (1995) 0.95
Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997). J Vet Intern Med (1999) 0.95
Alimentary lymphoma in cats: 28 cases (1988-1993). J Am Vet Med Assoc (1995) 0.94
Adherence column and buoyant density separation of bone marrow stem cells and more differentiated cells. J Cell Physiol (1971) 0.93
Total and partial orbitectomy for the treatment of periorbital tumors in 24 dogs and 6 cats: a retrospective study. Vet Surg (1997) 0.93
Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996). J Am Vet Med Assoc (2000) 0.92
Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med (1995) 0.91
Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. Clin Cancer Res (1998) 0.90
Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases. J Vet Med Sci (2006) 0.90
Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med (1998) 0.90
Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992). J Am Vet Med Assoc (1996) 0.90
Meeting the challenge of research in family medicine: report of The Study Group on Family Medicine Research. J Fam Pract (1982) 0.90
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res (1995) 0.89
In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest (1998) 0.89
Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma. J Vet Intern Med (2010) 0.89
Use of the polymerase chain reaction and oligonucleotide probes for the rapid detection and identification of Carnobacterium species from meat. J Appl Bacteriol (1992) 0.88
Matrix metalloproteinase-2 and -9 involvement in canine tumors. Vet Pathol (2003) 0.88
A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma. Vet Comp Oncol (2013) 0.87
Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor. Clin Cancer Res (1999) 0.87
Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases. Hum Gene Ther (1999) 0.87
Ultrasonography of canine gastric epithelial neoplasia. Vet Radiol Ultrasound (1998) 0.86
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study. Vet Comp Oncol (2011) 0.86
Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma. J Vet Intern Med (2014) 0.86
Limb-sparing treatment for osteosarcoma in dogs. J Am Vet Med Assoc (1989) 0.86
Retrospective study of orthovoltage radiation therapy for nasal tumors in 42 dogs. J Vet Intern Med (2001) 0.86
Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma. Vet Comp Oncol (2008) 0.86
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study. Vet Comp Oncol (2011) 0.86
Resection of pulmonary metastases in canine osteosarcoma: 36 cases (1983-1992). Vet Surg (1993) 0.86
In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells. Cancer Biother Radiopharm (1999) 0.86
Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology. Vet Pathol (2010) 0.85
Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma. J Vet Intern Med (2009) 0.85
Limb salvage surgery for osteosarcoma of the proximal humerus: outcome in 17 dogs. Vet Surg (1998) 0.84
Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Intern Med (1998) 0.84
Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med (2001) 0.83
p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Vet Pathol (2004) 0.83
An accelerated technique for irradiation of malignant canine nasal and paranasal sinus tumors. Vet Radiol Ultrasound (1998) 0.83
Idiopathic hematuria of unilateral renal origin in a dog. J Am Vet Med Assoc (1985) 0.82
Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminum sulfonated phthalocyanine. J Natl Cancer Inst (1991) 0.82
Jamshidi needle biopsy for diagnosis of bone lesions in small animals. J Am Vet Med Assoc (1988) 0.82
Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma. Cancer (1991) 0.82
Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. Drug Metab Dispos (1995) 0.81
Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987-1989). J Am Vet Med Assoc (1992) 0.81
Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs. Am J Vet Res (1992) 0.81
Outcome following treatment of vertebral tumors in 20 dogs (1986-1995). J Am Anim Hosp Assoc (2000) 0.81
Dose-escalating vinblastine for the treatment of canine mast cell tumour. Vet Comp Oncol (2008) 0.81
An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Vet Pathol (2003) 0.81
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma. Cancer Immunol Immunother (2005) 0.80
Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs. J Vet Intern Med (2009) 0.80
Treatment of nephroblastoma in a juvenile dog. J Am Vet Med Assoc (1995) 0.80
Single agent chemotherapy with doxorubicin for feline lymphoma: a retrospective study of 19 cases (1994-1997). J Vet Intern Med (2001) 0.80
Adjuvant chemotherapy using cisplatin by subcutaneous administration. In Vivo (1997) 0.80
Haemobartonellosis in a dog. Aust Vet J (1982) 0.79
Preclinical pharmacokinetics and antitumor activity of imexon. Invest New Drugs (1995) 0.79
Performance of preschoolers on the Pediatric Clinical Test of Sensory Interaction for Balance. Am J Occup Ther (1992) 0.79
Survival analysis of 97 cats with nasal lymphoma: a multi-institutional retrospective study (1986-2006). J Vet Intern Med (2009) 0.79
Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats. J Vet Intern Med (2008) 0.79
Apparent interaction of dimethyl sulfoxide with cisplatin released from polymer delivery devices injected subcutaneously in dogs. J Drug Target (1998) 0.79